Business
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
Leiden, the Netherlands, February 26, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the fourth quarter and full year 2025 and provide a business update on Thursday, March 12, 2026. Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CET/08:30 am EDT. To participate in the conference call or to watch the live webcast,
About this update from Pharming Group Nv
[{"type":"image","alt":"Pharming Group N.V.","displaySize":"","headline":null,"caption":"Pharming Group N.V.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":102,"url":"https://media.zenfs.com/en/globenewswire.com/e33000c1e8641d4ca14a349a419f6745"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6VI_P53XoKPQr35Rp9bMIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e33000c1e8641d4ca14a349a419f6745","width":300,"height":102}},"lazy":false},{"type":"text","content":"Leiden, the Netherlands, February 26, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the fourth quarter and full year 2025 and provide a business update on Thursday, March 12, 2026.","length":315,"tagName":"p"},{"type":"text","content":"Management will host a conference call and webcast for analysts and investors on the same day at 13:30 CET/08:30 am EDT.","length":120,"tagName":"p"},{"type":"text","content":"To participate in the conference call or to watch the live webcast, please register in advance using the links below.","length":117,"tagName":"p"},{"type":"text","content":"Conference call registration:https://register-conf.media-server.com/register/BIb3649a77439d4a2d8e5e002bac980cd1","length":112,"tagName":"p"},{"type":"text","content":"Once registered, dial-in information and a unique PIN will be provided, allowing access to the call.","length":100,"tagName":"p"},{"type":"text","content":"Please note, the Company will only take questions from dial-in attendees. ","length":73,"tagName":"p"},{"type":"text","content":"Webcast registration: https://edge.media-server.com/mmc/p/ddxigjqm","length":67,"tagName":"p"},{"type":"text","content":"The webcast will also be accessible on the Pharming website at Investors/Financial Documents, and a replay will be available shortly after the event.","length":149,"tagName":"p"},{"type":"text","content":"About Pharming Group N.V.Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics...